ITPRID2 and colonic neoplasm: These findings suggest that PDE4B may play a role in colon cancer and inhibition of PDE4B is a potential target for anticancer therapy We have demonstrated that FTO KD and inhibition with CS1 down-regulates PDE4B accounting for a possible mechanism of action of growth inhibition.